In November, Corvus plans to present new preclinical data highlighting the potential of soquelitinib to prevent lung damage, inflammation and pulmonary hypertension caused ... It affects up to 20% of ...
Health advocate, author and speaker Dr Fay Karpouzis talks about Lifestyle Medicine, an area which is becoming increasingly ...